Key Principles and Recommended Regimens for First-line Antiretroviral Therapy
Summary
- Genotypic resistance testing for reverse transcriptase and protease mutations is recommended for all patients newly diagnosed with HIV infection, even if treatment is not immediately initiated[DHHS ART; IASUSA ART; EACS ART]
- Resistance-associated mutations present at baseline may be associated with higher rates of virologic failure of those regimens, particularly for NNRTIs[Borroto-Esoda 2007; Kuritzkes 2008]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content